Marvell Technology, Inc. (NASDAQ: MRVL) is a fabless semiconductor company focused on data-infrastructure silicon, custom AI compute, and connectivity. Wall Street coverage is broad and decidedly bullish: a poll of roughly 47 analysts tracked by S&P Global shows a "Strong Buy" consensus with an average price target of about $340.56, rounding to the $340 used here. Independent aggregators show a similar picture, with TipRanks reporting an average target near $350 to $355.
The range is unusually wide — roughly $230 to $450 — reflecting genuine disagreement about how far Marvell's AI-driven growth can run. At the high end, Piper Sandler ($400), Bank of America ($400), Jefferies ($450), Evercore ISI ($433), Oppenheimer ($425), and RBC Capital ($425) emphasize custom-silicon "attach" and interconnect momentum. Stifel's Tore Svanberg holds a $370 target and, notably, reaffirmed his Buy rating even amid the recent Lumentum-related selloff. More cautious voices include Morgan Stanley ($300, Equal-Weight) and Raymond James, which moved to Outperform with a target near $300. This spread means the average target is a midpoint across very different views, not a guarantee. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
MRVL closed near $218 on October 29, 2026, down roughly 13% in a single session after a Bloomberg report that Marvell is in late-stage talks to acquire laser-chip maker Lumentum (LITE). The stock remains far below its 52-week high of $329.88 set in June 2026, though still up more than 150% year to date. With a market capitalization around $190 billion and a trailing P/E near 70, valuation is already rich.
Reaching $340 would require an advance of about 56% from current levels — a very large move that would likely need not only execution against Marvell's aggressive long-term framework but also continued expansion of AI capital spending and multiple expansion. The path is plausible only if the company repeatedly beats and raises expectations; it is not a function of mean reversion alone.
Marvell's October 2026 Investor Day materially reset expectations. Management raised its fiscal 2028 revenue outlook to $20 billion, projected its custom business would roughly triple from fiscal 2028 to fiscal 2029 to more than $12 billion, and guided to $70 billion to $90 billion of revenue and more than $30 in adjusted EPS by fiscal 2031. Recent quarters support the narrative: fiscal second-quarter revenue grew about 37% year over year. Analysts have responded with a wave of target increases, and demand for connectivity, optics, switching, and custom AI silicon remains a structural tailwind for the sector.
Several obstacles could keep MRVL well short of $340. The proposed Lumentum acquisition raised immediate concerns about dilution, leverage, and whether the deal makes strategic sense; Raymond James analyst Simon Leopold questioned whether it would scale. Valuation is stretched, with a forward P/E well above the industry average, leaving little room for error. Marvell's growth is also heavily concentrated in a handful of hyperscale AI customers, so any pause in cloud capital spending, a shift in custom-silicon share, or competition from larger rivals could compress the multiple and the estimate base simultaneously.
The $329.88 June 2026 peak now acts as a major resistance level, with the pre-acquisition-news range near $250 serving as nearer-term overhead. On the downside, the mid-$200s gave way quickly on the Lumentum report, leaving the $205-to-$218 zone as the first meaningful support level to watch. A durable break below that area would signal deeper consolidation, while any recovery would first need to reclaim the prior trading range before the $340 target becomes technically relevant.
Analyst price targets generally reflect a roughly 12-month research horizon, though Marvell's highest targets lean on longer-dated fiscal 2028 and fiscal 2031 frameworks that extend well beyond that window. Investors should watch the company's fiscal third-quarter earnings report, estimated for early December 2026, along with any formal announcement or termination of the Lumentum transaction, updates to custom-silicon design wins, hyperscaler capital-spending guidance, and any further analyst target revisions. From what I see, monitoring these catalysts closely helps frame the risk-reward picture.
I find Tickeron's AI Daily Buy/Sell Signals helpful for tracking names like this one. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. In my own process, it has served as a quick way to cross-check analyst moves and headline-driven volatility without replacing deeper fundamental work.
Can MRVL reach $340? The target is the average of roughly 47 analyst price targets and sits about 56% above current levels, so it represents a very large move rather than a near-term milestone. Strong AI-driven revenue growth, an aggressive long-term framework, and broad analyst support argue in its favor, while the Lumentum acquisition uncertainty, premium valuation, and hyperscaler concentration are meaningful counterweights. With targets spread from $230 to $450, even the bulls disagree on magnitude. Whether the stock reaches $340 will depend on execution against guidance, the resolution of the Lumentum situation, and the durability of AI infrastructure spending — not on the headline target itself.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for MRVL crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 10-day RSI Indicator for MRVL moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 27 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRVL as a result. In 79 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for MRVL turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 38 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
MRVL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRVL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 62 cases where MRVL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +7.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRVL advanced for three days, in 249 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
MRVL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 185 of 208 cases where MRVL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. MRVL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.525) is normal, around the industry mean (6.050). P/E Ratio (64.183) is within average values for comparable stocks, (18.007). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (3.761). Dividend Yield (0.001) settles around the average of (0.011) among similar stocks. P/S Ratio (21.552) is also within normal values, averaging (45.794).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the business of providing semiconductors to high-performance application-specific standard products
Industry Semiconductors